HUMAN PARVO VIRUS B19 IN NIGERIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

Authors

  • Abiodun Iyanda
    Ladoke Akintola University of Technology (LAUTECH), Ogbomoso, Oyo State
  • Oluyinka O. Opaleye
    Ladoke Akintola University of Technology, Ogbomoso

Keywords:

Human, Meta-analysis, Nigeria, Prevalence, Parvovirus B19

Abstract

Human Parvovirus B19 is an important pathogen that causes Erythema infectiosum (also known as fifth disease) in children, non-immune hydrops fetalis in pregnant women, aplastic crisis in sickle cell patients, anaemia in immunocompromised patients as well as arthralgia in seronegative immunocompetent individuals worldwide. Many studies on human infection with parvovirus B19 have been reported globally. However, a systematic review and meta-analysis of the infection has not been published in Nigeria. This study extracted articles pertaining to B19V infection in humans in Nigeria using four databases: Google Scholars, PubMed, web science, and African Journals OnLine (AJOL). We retrieved 24 articles related to B19V infection in Nigeria and these articles were retrieved from 1 January 2009 to 20 May 2024. It was estimated that the overall prevalence of humans with parvovirus B19 in the selected period was 25.9% (1377/4275). In the subgroup analysis, the prevalence of B19V was estimated to be 66.9%, 46.7%, 40.6%, 26.7% and 13.5% in the North West, North East, North Central, South South and South West of Nigeria, respectively. In sickle cell patients, the prevalence of B19 V was 34.2%. (17.7-57.0). By contrast, the prevalence of B19V in HIV patients was only 3.3%. (0.7-14.8). The prevalence of parvovirus B19 infection in pregnant women, sickle cell patients, children, blood donors, HIV patients, and hepatitis patients in Nigeria was found to be significantly different in the current review. It is recommended that periodic infection screening be incorporated into the routine clinical care of these patients.

Dimensions

Cotmore SF, et al ICTV Virus Taxonomy Profile: Parvoviridea. J Gen Virol. 2019 Mar; 100(3): 367-368

Ozawa K, Ayub J, Hao Y, et al. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 1987;61(8), 2395–2406.

Lamont R, Sobel J, Vaisbuch E, et al. Parvovirus B19 Infection in Human pregnancy. BJOG. 2011; 118 (2): 175 -186.

Habibzadeh S, Peeri-Doghagheh H, Mohammad-Shahi J, The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2016. Iran J Microbiol. 2016; 8 (3): 214-218.

Chirambo-Kalolekesha M, Kaile T, Mwaba F, Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV/AIDS at the Kitwe Central Hospital, blood bank. Afr Health Sci. 2018; 18(3): 496-502.

Jegede A, Aminu M, Ella EE. Sero-prevalence of human parvovirus B19 among patients attending some hospitals in Kano metropolis, Nigeria. Afr. J. Cln. Exper. Microbiol. 2014;15(1): 21-26

Ganaie S, Qiu J, Recent Advances in Replication and Infection of Human Parvovirus. Front Cell Infect Microbiol. 2018; 8: 166. https://doi.org/10.3389/fcimb.2018.00166. Gen Virol. 2016; 97(12): 3302-3312.

Tolfvenstam T, Papadogiannakis N, Norbeck O, et al. Frequency of human parvovirus B19 infection in intrauterine foetal death. Lancet, 2001; 357: 1494–1497

Qui J, Soderlund-Venermo M, Young NS, Human Parvoviruses. Clin Microbiol Rev. 2017 Jan; 30(1): 43-113. Published online 2016 Nov 2

Heegaard E.D, Brown K.E. Human Parvovirus B19. Clin. Microbiol. Rev. 2002;15:485–505. https://doi.org/10.1128/CMR.15.3.485-505.2002

Moher DD, Liberati A, Tetzlaff J. Group, Preferred 413 reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int. J. Surg. 2010’ 8, 336–441.

Joanna Briggs Institute. Critical appraisal tools. 2005

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin. Trials 1986;7 c(3), 177–188

Higgins JP, White IR, Anzures-Cabrera J. Meta-analysis of skewed data: combining results reported on log-transformed or raw scales. Stat Med. 2008; 27:6072–92.

Egger M, Davey-Smith G, Altman D, Systematic Reviews in Health Care: Meta-Analysis in Context. John Wiley & Sons, 2008

Duval S, Tweedie, R, A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J. Am. Stat. Assoc. 2000;95: 89–98.

Emiasegen SE, Nimzing L, Adoga MP, et al. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria. Mem Inst Oswaldo Cruz. 2011 Mar;106(2):227-31

Awolesi IP, John-Olabode SO, Olorunfemi G, et al. Prevalence and factors associated with parvovirus B19 infection among blood donors: a hospital-based study in South-West, Nigeria. Niger J Med 2020;29:203-7

Okojokwu, OJ, Adebayo MB, Abubakar BS, et al. Seroepidemiology of human parvovirus B19 infection among pregnant women in Abuja, Nigeria. Hosts and Viruses, 2018;5(5): 57-62.

Iheanacho MC, Akanmu SA, Nwogoh B. Seroprevalence of parvovirus BI9 antibody in blood donors and sickle cell disease patients at Lagos university teaching hospital (LUTH): a comparative study. Afr. J. Cln. Exper. Microbiol. 2014;15(1): 14-20

Ujo H, Mamman AI, Aliyu A, et al. The Sero-Prevalence of Parvovirus Antibodies among Children with Sickle Cell Anaemia in Zaria. Afr. J. Cln. Exper. Microbiol 2012:13(2): 74-78 http

Iyanda A, Opaleye OO, Ojurongbe O, et al. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Niger. J. Infect. Dev. Ctries. 2013;7(12): 946 – 950.

Ashaka OS, Agbede OO, Omoare AA, et al. Human parvovirus B19-induced anaemia in pre-school children in Ilorin, Nigeria. Afr J Lab Med. 2018;7(1), a615.

Ajagbe OR, Odaibo GN, Oluwaseun O, et al. Seroprevalence of acute human parvovirus B19 viraemia among anaemic children in ibadan city, Nigeria. J Acute Dis 2018;7:254-7

Iwalokun BA, Iwalokun SO, Hodonu SO. Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia. J Biomed Res 2013; 27(4): 27282.

Ashaka OS, Salu OB, James AB, et al. Parvovirus B19 DNA detection in treatment-naïve HIV anemic patients in Lagos, Nigeria: a case control study. Afri Health Sci. 2020;20(1):219-26.

Aleru BO, Olusola BA, Faneye AO, et al. Prevalence and Genotypes of Parvovirus B19 Among HIV Positive Children in Ibadan, Oyo State, Nigeria. Arch Basic Appl Med. 2018; 6(1): 113–117.

Iwalokun BA, Senapon OI, Semande OH, et al. A study on the association between parvovirus B19 infection, serum tumour necrosis factor and C-reactive protein levels among Nigerian patients with sickle cell anaemia. Singapore Med J 2012; 53(11) : 726

Opaleye OO, Fagbami AH, Lalremruata A, et al. Prevalence and Association of Human Parvovirus B19V With Hepatitis B and C Viruses in Nigeria. Journal of Medical Virology 2011. 83:710–716

Musa, SA, Banwat EB, Zhakom P, et al. Risk of Transfusion-Transmitted Human Parvovirus B19 Infection in Anyigba and Lokoja, Kogi State – Nigeria. Iosr Journal Of Pharmacy. Volume 3, Issue 3 (March 2013), Pp 66-70

Moses-Otutu IM, Okojie RO, Akinbo F, et al. Co-infection of Parvovirus B19 and Plasmodium falciparum among Sickle Cell Disease Patients in Benin City, Nigeria. Afr. J. Cln. Exper. Microbiol 2019:20(3).

Alao OO, Girei AI, Joseph DE, et al. Effect of socioeconomic demographic variables on Antiparvovirus B19 Antibody Seropositivity among Children with SCA in Jos, North Central Nigeria. The Internet Journal of Epidemiology. 2010; 8(2).

Bukar AA, Abjah UAM, Kagu MB, et al. Seroprevalence of parvovirus B19 and its clinical effect among anaemic SCA patients in Northeastern Nigeria. Am. J. Sci. Ind. Res., 2013, 4(2): 195-200.

Kolawole OE, Awoyelu HE, Oloke JK. Antibodies against human parvovirus B19 in pregnant women in Ogbomoso, Oyo State Nigeria. Journal of Immunoassay and Immunochemistry 2018;39(5)551-557

Ayolabi CI, Somtochukwu SO, Jefferey AE, et al. Detection of parvovirus B19 IgM in patients with sickle cell disease in Lagos, Nigeria. Asian Pac J Trop Dis 2017; 7(7): 430-432

Iheanacho MC, Akanmu AS, Nwogoh B. Sero-Prevalence of Human Parvo-Virus B19 Antibody in Paediatric Sickle Cell Disease Patients seen at the Lagos University Teaching Hospital (LUTH). Annals of Biomedical Sciences. 2014;13(1)

Abdullahi IN, Adekola HA, Emeribe AU, et al. Association of Hemoglobin Electrophoretic Phenotype with Human Parvovirus B19 infection among Pregnant Women attending Abuja Tertiary Hospital, Nigeria. mljgoums. 2020; 14 (3) :33-39

Ayolabi I, Audifferen T, Ibemgbo A, Occurrence Of Parvovirus B19 Infection Among Pregnant Women In Lagos, Nigeria. Egypt. Acad. J. Biolog. Sci., 2017;9(1): 51-56

Akyala IA, Amuta EU, Azua AT, Sero-Epidemiology of Human Parvo B19 Virus among Pregnant Women Attending Ante-Natal Federal Medical Center Keffi, Nasarawa State, Nigeria, International Journal of Virology and Molecular Biology, 2012;1(3):35-39.

Al Ghwass ME, El Shafei SM, Mohamed WS, et al. Seroprevalence of parvovirus B19 infection in patients with beta thalassemia major in Fayoum University Hospital. Egyptian Pediatric Association Gazette. 2016;64(3):126–30

Giorgio E, De Oronzo M, Iozza I, et al. Parvovirus B19 during pregnancy: a review. J Prenat Med 2010; 4(4): 63-66.

Obeid OE. Brief Original Article Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients. J Infect Dev Ctries 2011;5(7):535-339.

Obeid Mohamed, S.O.; Osman Mohamed, E.M.; Ahmed Osman, A.A.; Abdellatif MohamedElmugadam, F.A.; Abdalla Ibrahim, G.A. A Meta-Analysis on the Seroprevalence of Parvovirus B19 among Patients with Sickle Cell Disease. Biomed. Res. Int. 2019, 2019, 2757450

Li X, Lin Z, Liu J, Overall prevalence of human parvovirus B19 among blood donors in mainland China: A PRISMA-compliant meta-analysis. Medicine 2020; 99:17(e19832).

Azadmanesh K, Mohraz M, Kazemimanesh M, et al. Frequency and Genotype of Human parvovirus B19 Among Iranian Patients Infected With HIV. Journal of Medical Virology 2015. DOI: 10.1002/jmv.24169

Hsu TC, Chen TY, Lin MC, et al. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol. 2005 May;20(5):733-8. https://doi.org/10.1111/j.1440-1746.2005.03815.x. PMID: 15853987.

Toan NL, Song le H, Kremsner PG, et al. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol. 2006 Sep;45(3):361-9.

Wildig J, Michon P, Siba P, et al. Parvovirus B19 Infection Contributes to Severe Anemia in Young Children in Papua New Guinea. The Journal of Infectious Diseases 2006; 194:146–53.

Zaki MS, Hassan SA, Seleim T, et al. Parvovirus B19 infection in children with a variety of hematological disorders. Hematology. 2006 Aug;11(4):261-6

Yu X, Zhang J, Hong L, et al. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai. PLoS One. 2012;7(1):e29474.

Azzazy EA, Shaheen AA, Mousaad AA, et al. The prevalence of human parvovirus B19 infection in children with a variety of hematological disorders. Egypt J Haematol 2013;38:115-21

Zadsar M, Aghakhani A, Banifazl M et al. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors. J. Med. Virol. 2018; 90(8), 1318–1322.3

LaMonte AC, Paul ME, Read JS. Persistent Parvovirus B19 infection without the gdevelopment of chronic anaemia in HIV infected and uninfected children: the women and infant transmission study. J. Infec. Dis, 2003;189:847-851.9

Published

15-10-2025

How to Cite

Iyanda, A., & Opaleye, O. O. (2025). HUMAN PARVO VIRUS B19 IN NIGERIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. FUDMA JOURNAL OF SCIENCES, 9(10), 339-347. https://doi.org/10.33003/fjs-2025-0910-3955

How to Cite

Iyanda, A., & Opaleye, O. O. (2025). HUMAN PARVO VIRUS B19 IN NIGERIA: A SYSTEMATIC REVIEW AND META-ANALYSIS. FUDMA JOURNAL OF SCIENCES, 9(10), 339-347. https://doi.org/10.33003/fjs-2025-0910-3955